welcomes you to the new, improved website!The NCDB was queried to assess the optimal timing for resection after induction therapy for IIIA NSCLC. Survival was better in patients who underwent surgery in a short delay interval (114 days); short and medium delay intervals had similar outcomes.
You are here:
Optimal Surgical Timing After Neoadjuvant Therapy for Stage IIIa Non-Small Cell Lung Cancer
Submitted by: Emily Robinson
Source: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2019.09.076
Keywords:
Author(s): Jonathan D. Rice, Justin Heidel, Jaimin R. Trivedi, Victor H. van Berkel
